Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
Gynecologic Oncology|February 20, 2014
Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysisRoberto Vargas, J Alejandro Rauh-Hain, Joel Clemmer, et al.
Clinics (Sao Paulo, Brazil)|March 3, 2025
Pembrolizumab in gestational trophoblastic neoplasia: Systematic review and meta-analysis with sub-group analysis of potential prognostic factorsMarcio Barcellos, Antonio Braga, Matheus Machado Rech, et al.
Gynecologic Oncology|July 16, 2021
Folinic acid rescue during methotrexate treatment for low-risk gestational trophoblastic neoplasia - How much is just right?Juliana Gomes Poli, Gabriela Paiva, Fernanda Freitas, et al.
Clinical Ovarian Cancer and Other Gynecologic Malignancies|August 12, 2011
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian CarcinomaNeil S Horowitz, Richard T Penson, Dan G Duda, et al.
Gynecologic Oncology|January 13, 2019
Infection, thrombosis, and oncologic outcome after interval debulking surgery: Does perioperative blood transfusion matter?Beryl L Manning-Geist, Stephanie Alimena, Marcela G Del Carmen, et al.
The Journal of Pathology|July 26, 2018
Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomasThing Rinda Soong, Brooke E Howitt, Alexander Miron, et al.
Gynecologic Oncology|February 11, 2015
Does plastic surgical consultation improve the outcome of patients undergoing radical vulvectomy for squamous cell carcinoma of the vulva?Emeline M Aviki, Katharine M Esselen, Sara M Barcia, et al.
Gynecologic Oncology|April 3, 2019
Diagnosis and management of a recurrent polymerase-epsilon (POLE)-mutated endometrial cancerJennifer Taylor Veneris, Elizabeth K Lee, Emily A Goebel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancerUrsula A Matulonis, Neil S Horowitz, Susana M Campos, et al.
Gynecologic Oncology|September 21, 2020
Neoadjuvant chemotherapy does not disproportionately influence post-operative complication rates or time to chemotherapy in obese patients with advanced-stage ovarian cancerAlexa N Kanbergs, Beryl L Manning-Geist, Andrea Pelletier, et al.
Pageof 15